tiprankstipranks
Trending News
More News >
Glow Lifetech Corp (TSE:GLOW)
:GLOW
Advertisement

Glow LifeTech (GLOW) Price & Analysis

Compare
4 Followers

GLOW Stock Chart & Stats


Glow LifeTech News

GLOW FAQ

What was Glow Lifetech Corp’s price range in the past 12 months?
Glow Lifetech Corp lowest stock price was C$0.04 and its highest was C$0.12 in the past 12 months.
    What is Glow Lifetech Corp’s market cap?
    Glow Lifetech Corp’s market cap is C$11.05M.
      When is Glow Lifetech Corp’s upcoming earnings report date?
      Glow Lifetech Corp’s upcoming earnings report date is Nov 26, 2025 which is in 83 days.
        How were Glow Lifetech Corp’s earnings last quarter?
        Glow Lifetech Corp released its earnings results on Aug 27, 2025. The company reported -C$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.002.
          Is Glow Lifetech Corp overvalued?
          According to Wall Street analysts Glow Lifetech Corp’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Glow Lifetech Corp pay dividends?
            Glow Lifetech Corp does not currently pay dividends.
            What is Glow Lifetech Corp’s EPS estimate?
            Glow Lifetech Corp’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Glow Lifetech Corp have?
            Glow Lifetech Corp has 170,029,600 shares outstanding.
              What happened to Glow Lifetech Corp’s price movement after its last earnings report?
              Glow Lifetech Corp reported an EPS of -C$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Glow Lifetech Corp?
                Currently, no hedge funds are holding shares in TSE:GLOW

                Company Description

                Glow Lifetech Corp

                Glow Lifetech Corp., a biotechnology company, focuses on producing nutraceutical and cannabinoid-based products in North America. The company engages in the commercialization of two technologies, such as MyCell Enhanced technology, a nutraceutical and cannabis nutrient delivery technology; and a cannabis Smart Consumption System to assist users and patients to store, journal, control, consume, and manage cannabis related products. The company has the exclusive North American rights for the production, sale, and distribution rights for the certain micellization technology for cannabis and hemp derived ingredients, curcumin, vitamin K, and iron. It also engages in the business of secondary processing of ingredients to produce micellized materials from certain vitamins, nutraceuticals, and cannabis extracts that makes fat-soluble substances available for immediate absorption into the body reach near 100% bioavailability and water compatibility. The company was incorporated in 2018 and is based in Toronto, Canada.

                Glow LifeTech (GLOW) Earnings & Revenues

                Similar Stocks
                Company
                Price & Change
                Follow
                Innovotech
                Kane Biotech
                Britannia Life Sciences Inc
                BetterLife Pharma
                BioVaxys Technology

                Ownership Overview

                24.61%75.39%
                24.61% Insiders
                Mutual Funds
                ― Other Institutional Investors
                75.39% Public Companies and
                Individual Investors

                Options Prices

                Currently, No data available
                ---
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis